DAVIS PETER B 4
4 · NABI BIOPHARMACEUTICALS · Filed May 24, 2010
Insider Transaction Report
Form 4
DAVIS PETER B
Director
Transactions
- Purchase
Common Stock
2010-05-20$5.24/sh+3,816$19,996→ 14,630 total - Award
Stock Option (right to buy)
2010-05-20+20,000→ 20,000 totalExercise: $5.24Exp: 2017-05-20→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The purchase reported in this form was made upon election of director to receive his entire annual director fee retainer in common stock pursuant to Section 14 of the 2007 Omnibus Equity and Incentive Plan.
- [F2]The Stock Option (right to buy) is exercisable in four equal installments on August 20, 2010, November 20, 2010, February 20, 2011, and May 20, 2011.